The Clinical Reserch On Effects Bao Gan Xiao Zhi Granule On Scd-1in Non-Alchoholic Fatty Liver Patient With Depressed Liver And Deficient Spleen And Dyslipidemia

Objective:To observe the liver of traditional Chinese medicine reducing particles of nonalcoholic fatty liver disease SCD-1.The clinical efficacy of medicine and influence the safety, discussed the mechanism for this drug is widely used in clinical provides the basis.Method:Choose the criteria of nonalcoholic fatty liver disease patients randomized clinical trials according to plan, according to the order of the hospital were randomly divided into the treatment group and control group. A total of80patients, the treatment group and control group every40cases. Choose milk thistle capsule compared to the medicine, patients taking the liver disappear fat particles. The control group take milk thistle in the process of the capsule, banned the use of other and experimental drugs utility of Chinese and western medicine similar. Eight weeks after taking medicine. Two groups of patients before and after treatment observation of symptoms, signs, the liver function, SCD-1and liver and spleen CT.Results:Two groups of patients after therapy,, the treatment effect significantly, the treatment group in symptoms, liver function is improved, liver and spleen CT examination in the treatment group and control group statistical comparison no significant difference (P>0.05); Two groups of patients after treatment SCD-1significantly improve, after treatment, the two groups were compared, the difference was statistically significant (P<0.01).Conclusion:Bao gan xiao zhi granule and milk thistle capsule all can to Penn nonalcoholic fatty liver disease patients SCD-1have obvious effect of the rise, the treatment group than in control group; For clinical symptoms and liver function, blood fat indicators are obviously improved.